Product Name：Lixisenatide
CAS No.：320367-13-3；827033-10-3；1997361-87-1
Synonyms：利西拉来
Catalog No.：218P139
Brand：HongTide（上海鸿肽生物）
Description：利西拉来（Lixisenatide）是目前用于治疗糖尿病的药物，并且也是GLP-1的受体激动剂，本公司生产的是多肽产品，序列中含有44个氨基酸，是一条碱性多肽。利西拉来(Lyxumia)于2013年在欧洲获得上市批准，以利西拉来为主要原料的药物属注射用糖尿病治疗药物，一天注射一次，连同其它药物或者胰岛素一块使用，适用于只能通过药物来控制血糖水平的患者。
Lixisenatide is currently used to treat diabetes and is also a receptor agonist for GLP-1. What our company produces is a peptide, which contains 44 amino acids in its sequence and is a basic peptide. Lyxumia was approved for marketing in Europe in 2013. The drug with Lyxumia as the main raw material is a drug for diabetes injection, which is injected once a day, together with other drugs or insulin. It is applicable to patients who can only control the blood sugar level through drugs.
Purity (HPLC) ≥98.0%
Single impurity≤2%
Peptide content≥75.0%
Amino Acid Composition≤±15%
Bacterial Endotoxins≤50EU/mg
Solubility：H2O/DMSO
Vacuum-packed with aluminum foil bag or transparent bag.Various weights can be packed according to your requirements.
Storage:Cool dry place( Store at -20°C, away from the light)
Remark:For Research Use Only. Not for human use.
Sequence(1-letter code) | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2 |
Sequence(3-letter code) | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2 |
Peptide Structure | 
|
Molecular Formula | C215H347N61O65S |
Molecular Weight | 4858.56 |
订购联系方式：
上海鸿肽生物科技有限公司
手机： +86-18018095145 （同微信号）
QQ: 3259098395
邮箱：sales1@hongtide.com
关键字： 320367-13-3;827033-10-3;1997361-87-1;利西拉来;Lixisenatide;
上海鸿肽生物科技有限公司（简称：鸿肽生物）是一家以多肽以及多肽上下游产品研发、生产、销售以及技术转让为主要业 务科技公司。公司现有产品涵盖：定制多肽、目录多肽、氨基酸衍生物、小分子化合物；公司自成立以来，秉持“用质量作船， 以服务为帆，为科研服务”的企业理念，为国内外众多科研工作者提供了优质的服务及产品。